Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04690374

Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor

Desmoplastic Small Round Cell Tumor Clinical Trial

Official title:
Registry for Patients With Desmoplastic Small Round Cell Tumor

Clinical Trial Summary

This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information about a group of people, and it is usually focused on a specific diagnosis or disease. The purpose of this registry is to create a database- a collection of information-or better understanding DSRCT. Researchers will use the information from this database to learn more about DSRCT and for current and future research on DSRCT.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Desmoplastic Small Round Cell Tumor
Clinical Trial Details
NCT number NCT04690374
Study type Observational [Patient Registry]
Source Memorial Sloan Kettering Cancer Center
Contact Emily Slotkin, MD
Phone 1-833-675-5437
Email slotkine@mskcc.org
Status Recruiting
Phase
Start date December 22, 2020
Completion date December 2027
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06456359 - Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor Phase 2
Active, not recruiting NCT04095221 - A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma Phase 1/Phase 2
Active, not recruiting NCT02834169 - French National Registry of Rare Peritoneal Surface Malignancies N/A
Active, not recruiting NCT03600649 - Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas Phase 1
Recruiting NCT03618381 - EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults Phase 1
Recruiting NCT04897321 - B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) Phase 1
Recruiting NCT05918640 - Lurbinectedin in FET-Fused Tumors Phase 1/Phase 2
Terminated NCT04901806 - Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors Phase 1
Recruiting NCT04022213 - A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum Phase 2
Active, not recruiting NCT04483778 - B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults Phase 1
Active, not recruiting NCT04145349 - CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor Phase 1/Phase 2
Suspended NCT01125449 - Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease Phase 2
Enrolling by invitation NCT05266196 - A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) Phase 1/Phase 2
Not yet recruiting NCT06277154 - MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma Phase 2
Completed NCT00436657 - Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer Phase 1
Active, not recruiting NCT01946529 - Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors Phase 2
Not yet recruiting NCT02982486 - A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma Phase 2
Completed NCT02982941 - Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors Phase 1
Recruiting NCT04530487 - Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults Phase 2
Recruiting NCT03967834 - Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group N/A